JBJasneet Singh Bhullar

Jasneet Singh Bhullar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jasneet Singh Bhullar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Gokulakkrishna Subhas

    Department of Surgery, Providence Hospital and Medical Centers, 16001 West 9 Mile Road, Southfield, MI 48075, USA

    2 shared publications
  • Vijay K. Mittal

    Department of Surgery, Ascension Providence Hospital/Michigan State University College of Human Medicine, Southfield, MI, USA; Department of Medical Education, Ascension Providence Hospital/Michigan State University College of Human Medicine, Southfield, MI, USA

    2 shared publications
  • Ahmed K. Alomari

    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA

    1 shared publication
  • Boris Silberberg

    Department of Patient Care Research, Providence Hospital and Medical Centers, Southfield, MI

    1 shared publication
  • Gurteshwar Rana

    Department of Surgery, Providence Hospital and Medical Centers, 16001 West 9 Mile Road, Southfield, MI 48075, USA

    1 shared publication
  • Jacqueline Tilak

    Department of Patient Care Research, Providence Hospital and Medical Centers, Southfield, MI

    1 shared publication

Latest Publications

  • Practice Variation in Anal Fistula Management

    by Saleh A. Busbait, Koby Herman, Jasneet S. Bhullar

    Treatment of anal fistula still poses the greatest challenge for anorectal surgeons. Despite the rise of sphincter-sparing surgeries, there is no clear evidence that suggests their superiority over each other. Therefore, modern guidelines acknowledge several techniques as acceptable due to lack of universal standard of care. Practice variability is caused by complex anatomy of the disease and the existence of community-wide equipoise. Fistula treatment continues to be challenging in terms of achieving the optimal balance between fistula eradication and continence preservation. Patient decision-making is guided by personal risk and benefit calculations, surgical experience, and individual patient preference. Moreover, interpretation of the existing research on this topic is complicated by different approaches to defining both clinical and radiological healing, recurrence, as well as quality-of-life parameters. Surgical practice variability in anal fistula management is due to both individualized clinical approach and the presence of significant shortcomings within the methodology of the current literature. It is critical for major societies in the field of colorectal surgery to establish a mandatory reporting on standardized outcomes, in particular the Anal Fistula Core Outcome Set and standardized imaging criteria, for eliminating unjustified variability and implementing evidence-based surgical strategies.

  • Thirty-day readmissions after inpatient laparoscopic cholecystectomy: factors and outcomes

    by Gurteshwar Rana, Jasneet Singh Bhullar, Gokulakkrishna Subhas, R.B. Kolachalam, V.K. Mittal


  • A True Orthotopic Gastric Cancer Murine Model Using Electrocoagulation

    by Jasneet Singh Bhullar, Tafadzwa Makarawo, Gokulakkrishna Subhas, Ahmed Alomari, Boris Silberberg, Jacqueline Tilak, Milessa Decker, Vijay K. Mittal

    Orthotopic mouse models of human gastric cancer represent an important in vivo tool for testing chemotherapeutic agents and for studying intraluminal factors. Currently, orthotopic mouse models of gastric cancer require an operative procedure involving either injection or implantation of tumor cells in stomach layers. The resultant tumor does not grow from the stomach's mucosal surface, so it does not mimic the human disease process. A low-dose gastric mucosal coagulation was done transorally in the body of stomach using a specially designed polyethylene catheter in 16 female severe combined immunodeficient mice. This was followed by the instillation of SNU-16 human gastric cancer tumor cells (1 × 10(6) cells). Five mice each were euthanized at 1 and 2 months, and 6 mice were euthanized at 3 months. Three control mice underwent electrocoagulation alone and 3 mice underwent cell line instillation alone. Tumors were detected in 11 of 16 experimental mice, but not in the control mice. Tumors were noted in mice at 1 month. Over time, there was an increase in tumor growth and metastasis to lymph nodes and surrounding organs. Histopathologic evaluation showed that the tumors grew from the gastric mucosa. Our model is easy to create and overcomes the limitations of the existing models, as the tumor arises from the stomach's mucosal layer and mimics the human disease in terms of morphology and biologic behavior. This is the first report of a true orthotopic gastric cancer murine model. This model opens new doors for additional studies that were not possible earlier.